Intercept Pharmaceuticals, Inc. (ICPT): Price and Financial Metrics
Intercept Pharmaceuticals, Inc. (ICPT)
Today's Latest Price: $110.48 USD
9.30 (-7.76%)
Updated Dec 6 10:12am
Add ICPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ICPT Stock Summary
- ICPT's price/sales ratio is 11.36; that's higher than the P/S ratio of 90.66% of US stocks.
- ICPT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 93.23% of US stocks.
- Revenue growth over the past 12 months for Intercept Pharmaceuticals Inc comes in at 38%, a number that bests 86.38% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Intercept Pharmaceuticals Inc, a group of peers worth examining would be CERS, NSTG, PLUG, PACB, and VUZI.
- ICPT's SEC filings can be seen here. And to visit Intercept Pharmaceuticals Inc's official web site, go to www.interceptpharma.com.
ICPT Daily Price Range
ICPT 52-Week Price Range
ICPT Stock Price Chart More Charts
ICPT Price/Volume Stats
Current price | $110.48 |
Prev. close | $119.78 |
Day low | $107.36 |
Day high | $120.57 |
50-day MA | $79.11 |
200-day MA | $82.11 |
52-week high | $131.87 |
52-week low | $56.76 |
Volume | 516,187 |
Avg. volume | 739,915 |
Dividend yield | N/A |
Market Cap | 3.62B |
Intercept Pharmaceuticals, Inc. (ICPT) Company Bio
Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases. The company was founded in 2002 and is based in New York, New York.
Loading social stream, please wait...